Tenet Healthcare Corporation (THC) Stock Forecast
THC analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.43 / 5 from 23 analysts
- Price target
- $286.41 average of analyst targets
- Upside to target
- +7.2% from the latest close
- Next earnings
- October 29, 2026 EPS estimate $4.59
- 52-week range
- $161.37 – $280.77
THC analyst ratings
23 analystsNumber of analysts at each rating.
THC price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
THC earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $4.67 | $4.03 | $5.04 | $3.70 | +26.3% | 20 |
| Current fiscal year (2026) | $21.22 | $20.66 | $21.65 | $16.78 | +26.5% | 21 |
| Next fiscal year (2027) | $21.08 | $18.89 | $23.21 | $21.22 | −0.7% | 21 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
THC revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $5.51B | $5.42B | $5.89B | +4.2% | 19 |
| Current fiscal year (2026) | $22.42B | $22.09B | $24.26B | +5.2% | 21 |
| Next fiscal year (2027) | $22.52B | $21.96B | $23.30B | +0.4% | 20 |
THC EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
THC revenue: reported and forecast
THC EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $4.09 | $4.67 | $4.67 | $4.67 | $4.67 | +14.1% | 1 up · 1 down |
| Current fiscal year (2026) | $17.85 | $21.21 | $21.22 | $21.22 | $21.22 | +18.9% | 0 up · 1 down |
| Next fiscal year (2027) | $17.79 | $20.83 | $21.08 | $21.08 | $21.08 | +18.5% | 0 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
THC earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; THC beat in 12 of 12.
What analysts expect from THC
23 analysts cover Tenet Healthcare; their consensus rating is buy (4.43 on a 1–5 scale, where 5 is a strong buy). The average price target is $286.41, 7.2% above the latest close of $267.25. Analysts expect earnings of $21.22 per share for 2026, +26.5% from a year earlier. For 2027 the average estimate is $21.08 per share on revenue of $22.5 billion. Tenet Healthcare beat the EPS estimate in 12 of the last 12 quarters.
Related: THC income statement, THC key metrics, THC chart. See the THC stock overview for the latest quote and news.
THC forecast FAQ
What is Tenet Healthcare's price target?
The average analyst price target for Tenet Healthcare is $286.41, 7.2% above the latest close of $267.25.
Is Tenet Healthcare a buy, hold or sell?
Of 23 analysts covering Tenet Healthcare, 14 rate it a strong buy, 5 a buy, 4 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Tenet Healthcare's EPS forecast?
Analysts forecast $21.22 per share for 2026 (range $20.66 to $21.65); for 2027 the estimate is $21.08.
What is Tenet Healthcare's revenue forecast?
The average revenue estimate for 2026 is $22.4 billion, growth of 5.2%; for 2027 it is $22.5 billion.
When does Tenet Healthcare report earnings?
Tenet Healthcare is expected to report results for the quarter ending September 30, 2026 on October 29, 2026 before the market opens; the EPS estimate is $4.59.
Does Tenet Healthcare usually beat earnings estimates?
Tenet Healthcare reported EPS at or above the analyst estimate in 12 of the last 12 quarters.